Insmed shares slip as CFO Sara Bonstein steps down
** Shares of drugmaker Insmed INSM.O fall more than 3% to $107.59 premarket
** Sara Bonstein to step down as CFO, effective Oct 30
** Sara to remain till month-end to ensure a smooth transition through the company's Q3 financial results reporting on Oct 29
** Prior to joining Insmed, Sara served as the CFO at OncoSec Medical
** Co reaffirms FY26 guidance and has commenced a search to identify the next CFO
** All 25 brokerages covering the stock are bullish; median PT - data compiled by LSEG
** As of last close, stock has fallen 36.15% YTD